Back
Speaker illustration

Doctor Akihiro Nakamura

Iwate Prefectural Central Hospital, Morioka (Japan)

Presentations

Impact of pemafibrate on lipid profile and insulin resistance in patients with statin-treated coronary artery disease with metabolic syndrome

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session: Hypertriglyceridemia treatment: CEPT, icosapent ethyl, and fibrates

Access
Like
Thumbnail

Efficacy and safety of pemafibrate versus bezafibrate in coronary artery disease patients receiving statin treatment: a randomized, open-label, cross-over study

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session: Current issues in lipid-lowering therapy

Access
Like
Thumbnail

Effects of evolocumab on plasma levels of proprotein convertase subtilisin/kexin type 9 and lipoprotein(a) in acute myocardial infarction

Event: ESC Congress 2020

Topic: Lipid-Lowering Agents

Session: Pharmacology and Pharmacotherapy ePosters

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources